Teva Acquisition Spree Gives Firm A Boost With Analysts
Executive Summary
Anticipation of another merger is helping Teva improve its standing with Wall Street analysts.
You may also be interested in...
Schering AG U.S. Expansion Plans Call For Sales Of $1.6 Bil. In 2005
Schering AG expects its U.S. business to approach $1.6 bil. in revenues by 2005, more than double its projected 1999 level of $750 mil.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011